Latest Content

PSMA-Targeted Radiation Drug for Prostate Cancer Subset Meets Study Goal

November 22nd 2024, 10:00pm

By Ryan Scott

Patients with PSMA-positive metastatic castration-resistant prostate cancer showed benefits after receiving PSMA-targeted treatment.

Initial Keytruda May Be Beneficial in Patients With Advanced Bladder Cancer

November 22nd 2024, 8:00pm

By Spencer Feldman

Article

Initial Keytruda showed consistent antitumor activity and safety in patients with advanced bladder cancer ineligible for platinum-based chemotherapy.

When Faced With a Cancer-Related Trigger

November 22nd 2024, 6:00pm

By Linda Cohen

Article

When I am triggered by something related to the cancer I have, I start going down a negative rabbit hole but remind myself to be vigilant when this happens.

‘One Tree Hill’ Actor Dies of Cancer, ‘Jeopardy!’ Contestant Reveals Diagnosis and More

November 22nd 2024, 4:00pm

By Alex Biese

Article

From the deaths of actor Paul Teal and Chicago Bulls player Bob Love to a contestant on “Jeopardy!” revealing his colon cancer diagnosis, here’s what’s happening in the oncology space this week.

Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC

November 22nd 2024, 2:00pm

By Ashling Wahner

Article

Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel.

Subcutaneous Keytruda Plus Berahyaluronidase Alfa Combo Meets Phase 3 Trial End Points in NSCLC

November 21st 2024, 10:03pm

By Ryan Scott

Article

Treatment with subcutaneous Keytruda plus berahyaluronidase alfa meets phase 3 trial end points in the treatment of metastatic non–small cell lung cancer.

UGN-102 Shows Promising Treatment Responses in Recurrent Bladder Cancer

November 21st 2024, 8:00pm

By Ashley Chan

Article

Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses.

Feelings of Gratitude in November as a Colon Cancer Survivor

November 21st 2024, 6:00pm

By Carla Deschamps

Article

With Thanksgiving coming soon, I find that November is the perfect time to reflect and gather feelings of gratitude as a cancer survivor.

Radiotherapy and EGFR-TKIs May Improve Treatment Outcomes in Lung Cancer

November 21st 2024, 4:00pm

By Alex Biese

Article

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of radiotherapy to TKI treatment.

FDA Approves Ziihera for Some With Biliary Tract Cancer

November 21st 2024, 2:15pm

By Alex Biese

Article

The agency has approved Ziihera for adults with previously treated, unresectable or metastatic HER2-positive biliary tract cancer.

PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy

November 20th 2024, 10:00pm

By Gina Mauro

Article

PD-L1 expression was found to predict better outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 levels were linked to worse outcomes.